IP Library Granted Patent US 7,767,419
Granted Patent B2
US 7,767,419 · App. 10/359,028 · Granted Aug 3, 2010

Calibrator for NT-proBNP immunoassay

Assignee: Nexus DX, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,767,419
App. No.
10/359,028
Granted
Aug 3, 2010
Kind
B2
Abstract

The invention provides a method to efficiently express high levels of a recombinant untagged NT-proBNP for use as a calibrator in NT-proBNP immunoassays.

Claims (11)

1. A stepwise method for expression of NT-BNP (N-terminus brain natriuretic peptide) in Escherichia coli ( E. coli ) without an N-terminal histidine affinity chromatography tag for purification comprising sequentially:

a) introducing SEQ ID NO:1 at the 5′ end of a nucleic acid encoding for NT-BNP;

b) replacing codons 3 through 12 of said nucleic acid encoding for NT-BNP of step a with SEQ ID NO:2;

c) deleting codons 1 and 2 of said nucleic acid encoding for NT-BNP of step b; and

d) transfecting an E. coli culture with the nucleic acid of step c wherein said E. coli culture then expresses NT-BNP without said affinity chromatography based tag for purification.

2. The method of claim 1 further comprising purifying said NT-BNP from said E. coli culture.

3. The method of claim 2 wherein said purifying is carried out by fast/performance liquid chromatography (FPLC).

4. The method of claim 1 wherein the NT-BNP is an N-terminal fused peptide that comprises a mutated phage T7 gene 10-translation initiation region and does not include any other N-terminus affinity chromatography tag for purification.

5. A method for expressing a NT-BNP (N-terminus brain natriuretic peptide) in Escherichia coil ( E. coli ) without an N-terminal histidine affinity chromatography tag for purification, the method comprising:

a) constructing an expression plasmid, the expression plasmid comprising, in contiguously linked sequence, SEQ ID NO:1, SEQ ID NO:2, and the nucleic acid sequence encoding N-terminal brain naturetic peptide from codon 13 to codon 76; and

b) transfecting an E. coli culture with the expression plasmid of step a wherein said E. coli culture then expresses NT-BNP.

Assignments (13)
RELEASE OF SECURITY INTEREST Recorded May 7, 2018
From: COMERICA BANK
To: NEXUS DX, INC.
Reel/Frame 045735/0714 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 5, 2011
From: NEXUS DX, INC.
To: COMERICA BANK
Reel/Frame 026079/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2010
From: FINANCIERE ELITECH SAS
To: DXCON, INC.
Reel/Frame 024251/0547 →
ASSET PURCHASE AGREEMENT Recorded Apr 19, 2010
From: NANOGEN, INC.
To: FINANCIERE ELITECH SAS
Reel/Frame 024251/0679 →
CHANGE OF NAME Recorded Apr 19, 2010
From: DXCON, INC.
To: NEXUS DX, INC.
Reel/Frame 024251/0965 →
GRANT OF SECURITY INTEREST Recorded Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018187/0834 →
CHANGE OF NAME Recorded Jul 3, 2006
From: SYN X PHARMA INC.
To: NANOGEN POINT OF CARE INC.
Reel/Frame 017881/0996 →
SECURITY INTEREST Recorded Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
SECURITY AGREEMENT Recorded Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2003
From: ALVI, AZHAR; YAJIMA, WILLIAM; SIKORA, ROSHANA; JACKOWSKI, GEORGE; HONG, MEE-RA
To: SYN X PHARMA, INC.
Reel/Frame 013912/0474 →
Continuity (1)
Related Publication 20040152128A1 · Aug 5, 2004